The Ocular Oncology Laboratory is dedicated to research leading directly to better treatments for ocular tumors. The focus is on combined modality focal therapies. Experimental models are utilized to investigate tumor responses to periocular chemotherapy, external beam radiotherapy, and hyperthermia. The lab actively translates new findings to the clinic.
Directed by Dr. Harbour, the lab focuses on the identification of genetic, epigenetic and genomic abnormalities that lead to poor patient outcome in uveal melanoma, retinoblastoma and other eye cancers, with the goal of developing more accurate prognostic biomarkers and targeted molecular therapies that will lead to improved survival.
Research Interests: Clinical Trials for High Risk Uveal Melanoma and Retinoblastoma, Intraocular Lymphoma, Hereditary Eye Tumors, Ocular Biopsy, Using Genetic and Genomic Methods to Develop New Diagnostic, Prognostic and Therapeutic Technologies for Eye Cancers.